© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, CG Oncology, Inc. Common stock (CGON) shows an Average True Range (ATR) of 3.12 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 991.25K, indicating liquidity. These fundamental metrics provide insight into CGON's underlying financial health and market activity.
| ATR | 3.12 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 991.25K |
| Avg Vol (10 Days) | 944.09K |
CG Oncology, Inc. Common stock (CGON) technical indicators as of January 21, 2026: the SMA 20 is 20.76%, SMA 50 at 27.32%, and SMA 200 at 67.15%. The RSI 14 value is 70.48, suggesting its current momentum. These technical analysis signals help assess CGON's price trends and potential future movements.
| SMA 20 | 20.76% |
| SMA 50 | 27.32% |
| SMA 200 | 67.15% |
| RSI 14 | 70.48 |
CG Oncology, Inc. Common stock (CGON) stock performance overview as of January 21, 2026: The 52-week high is $57.4 (currently -4.71% below), and the 52-week low is $14.8 (currently 269.53% above). Over the past year, CGON's performance is 87.94%, compared to the S&P 500's 9.18% change.
| 52-Week High | 57.4 |
| 52-Week High Chg | -4.71% |
| 52-Week Low | 14.8 |
| 52-Week Low Chg | +269.53% |
| S&P 500 52-Week Chg | 9.18% |
According to market data, CG Oncology, Inc. Common stock (CGON) stock's recent performance metrics show that over the last month, CGON is 46.35%, with a Year-to-Date (YTD) performance of 31.72%. Over the past year, the stock has seen a 87.94% change. These figures summarize CGON's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 56.43 | 57.4 | 57.4 | 57.4 | 57.4 | 57.4 |
| Low | 51.58 | 37.01 | 35.8 | 23.65 | 14.8 | 39.14 |
| Performance | +1.81% | +46.35% | +31.91% | +103.31% | +87.94% | +31.72% |
According to current financial data, CGON stock's P/E (TTM) ratio is -27.46, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for CGON, including P/S (2011.46), P/B (6.05), and P/FCF (-37.33), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | CGON | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -27.46 | -1.23 | -5.15 | 32.59 |
| P/S (TTM) | 2011.46 | 3.71 | 465.3 | 5.98 |
| P/B (TTM) | 6.05 | -0.77 | 9.35 | 5.66 |
| P/FCF (TTM) | -37.33 | -2.16 | -348.58 | 33.18 |